RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.06%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.94B
AUM Growth
+$2.94B
(+14%)
Cap. Flow
+$60.2M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
91
New
27
Increased
20
Reduced
25
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$80M |
| 2 |
uniQure
QURE
|
$61.4M |
| 3 |
Labcorp
LH
|
$51.8M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$45.8M |
| 5 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$38.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$78.7M |
| 2 |
Puma Biotechnology
PBYI
|
$74.6M |
| 3 |
Penumbra
PEN
|
$65.6M |
| 4 |
Regenxbio
RGNX
|
$40.9M |
| 5 |
Abbott
ABT
|
$39.4M |
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.03% |
| 3 | Technology | 0.19% |
| 4 | Communication Services | 0% |
